5-Hydroxyindolacetic Acid and Homovanillic Acid in Cerebrospinal Fluid in Manic-depressive Psychosis

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1972 Jun 1

PMID 4655292

Citations 23

Authors

R Sjostrom

B E ROOS

Affiliations

Soon will be listed here.

Citing Articles

Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

van Enkhuizen J, Geyer M, Minassian A, Perry W, Henry B, Young J Neurosci Biobehav Rev. 2015; 58:4-18.

PMID: 26297513 PMC: 4684462. DOI: 10.1016/j.neubiorev.2015.08.008.

The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

van Enkhuizen J, Janowsky D, Olivier B, Minassian A, Perry W, Young J Eur J Pharmacol. 2014; 753:114-26.

PMID: 25107282 PMC: 4318788. DOI: 10.1016/j.ejphar.2014.05.063.

Serotonin and 5-hydroxy indole acetic acid in infantile hydrocephalus.

Gopal S, Sharma V, Chansuria J, Gangopadhyaya A, Singh T Pediatr Surg Int. 2007; 23(6):571-4.

PMID: 17380338 DOI: 10.1007/s00383-006-1689-5.

Dopamine and depression.

Brown A, Gershon S J Neural Transm Gen Sect. 1993; 91(2-3):75-109.

PMID: 8099801 DOI: 10.1007/BF01245227.

5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Goodwin F, Post R Br J Clin Pharmacol. 1983; 15 Suppl 3:393S-405S.

PMID: 6190490 PMC: 1427648. DOI: 10.1111/j.1365-2125.1983.tb02130.x.

References

Dunner D, Cohn C, Gershon E, Goodwin F . Differential catechol-O-methyltransferase activity in unipolar and bipolar affective illness. Arch Gen Psychiatry. 1971; 25(4):348-53. DOI: 10.1001/archpsyc.1971.01750160060011. View

BOWERS Jr M . Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid. Brain Res. 1969; 15(2):522-4. DOI: 10.1016/0006-8993(69)90174-7. View

Neef N, Tozer T, Brodie B . Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J Pharmacol Exp Ther. 1967; 158(2):214-8. View

van Praag H, Korf J, Puite J . 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature. 1970; 225(5239):1259-60. DOI: 10.1038/2251259b0. View

BOWERS Jr M, Gerbode F . Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature. 1968; 219(5160):1256-7. DOI: 10.1038/2191256a0. View

Persson T, ROOS B . Clinical and pharmacological effects of monoamine precursors or haloperidol in chronic schizophrenia. Nature. 1968; 217(5131):854. DOI: 10.1038/217854a0. View

Moir A, Ashcroft G, Crawford T, Eccleston D, Guldberg H . Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 1970; 93(2):357-68. DOI: 10.1093/brain/93.2.357. View

Dencker S, Malm U, ROOS B, WERDINIUS B . Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J Neurochem. 1966; 13(12):1545-8. DOI: 10.1111/j.1471-4159.1966.tb04320.x. View

Guldberg H, Ashcroft G, Crawford T . Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 1966; 5(17):1571-5. DOI: 10.1016/0024-3205(66)91026-5. View

10.

Ashcroft G, Crawford T, Eccleston D, SHARMAN D, MACDOUGALL E, Stanton J . 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet. 1966; 2(7472):1049-52. DOI: 10.1016/s0140-6736(66)92028-9. View

11.

Persson T, ROOS B . Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics. Br J Psychiatry. 1969; 115(518):95-8. DOI: 10.1192/bjp.115.518.95. View

12.

Fuxe K . EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM. Acta Physiol Scand Suppl. 1965; :SUPPL 247:37+. View

13.

ROOS B . Effects of certain tranquillisers on the level of homovanillic acid in the corpus striatum. J Pharm Pharmacol. 1965; 17(12):820-1. DOI: 10.1111/j.2042-7158.1965.tb07615.x. View

14.

BOWERS Jr M, Heninger G, GERBODE F . Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. Int J Neuropharmacol. 1969; 8(3):255-62. DOI: 10.1016/0028-3908(69)90046-x. View

15.

FOTHERBY K, Ashcroft G, AFFLECT J, Forrest A . Studies on sodium transfer and 5-hydroxyindoles in depressive illness. J Neurol Neurosurg Psychiatry. 1963; 26:71-3. PMC: 495538. DOI: 10.1136/jnnp.26.1.71. View

16.

Gottfries C, GOTTFRIES I, Johansson B, Olsson R, Persson T, ROOS B . Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology. 1971; 10(6):665-72. DOI: 10.1016/0028-3908(71)90081-5. View

17.

Korf J, van Praag H . The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia. 1970; 18(1):129-32. DOI: 10.1007/BF00402393. View

18.

ANDEN N, CORRODI H, Fuxe K, HOKFELT B, Hokfelt T, Rydin C . Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 1970; 9(9):513-23. DOI: 10.1016/0024-3205(70)90207-9. View

19.

Chase T, Schnur J, Gordon E . Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology. 1970; 9(3):265-8. DOI: 10.1016/0028-3908(70)90075-4. View

20.

Carlsson A, Lindqvist M . EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh). 1963; 20:140-4. DOI: 10.1111/j.1600-0773.1963.tb01730.x. View